Glucomust-PM Tablet ER
Glucomust-PM Tablet ER
Glibenclamide (5mg) + Metformin (500mg) + Pioglitazone (15mg)
Cheaper alternative availability
Already at the Best Price
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
About This Medicine
Product description & overview
Glucomust-PM Tablet ER: Comprehensive Blood Sugar Management
Glucomust-PM Tablet ER provides a powerful three-drug combination to effectively manage blood sugar levels. This extended-release tablet combines Glibenclamide (5mg), Metformin (500mg) and Pioglitazone (15mg) for comprehensive control.
Glibenclamide: A fast-acting sulfonylurea, it stimulates insulin secretion from the pancreas, improving glucose uptake and lowering blood sugar levels.
Metformin: This first-line treatment for type 2 diabetes helps reduce glucose production in the liver and promotes glucose utilization by muscles.
Pioglitazone: A thiazolidinedione, it works by increasing insulin sensitivity and reducing glucose production, contributing to improved blood sugar control.
Glucomust-PM Tablet ER is intended for patients diagnosed with type 2 diabetes. This formulation offers convenience as the extended-release mechanism delivers the medication gradually over time, minimizing fluctuations in blood sugar levels and maximizing efficacy.
Note: Always consult with a healthcare professional before starting or changing any medications.
Active composition
Metformin 500 mg
+2 more active ingredients
About Metformin
Metformin is an oral antihyperglycemic agent used to manage type 2 diabetes mellitus. It works by decreasing glucose production in the liver and improving insulin sensitivity. Metformin is effective in controlling blood sugar levels and preventing diabetes-related complications. In summary, Metformin is vital for managing type 2 diabetes.
How It Works
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
All Active Ingredients
Glibenclamide
Glibenclamide binds to sulfonylurea receptors on pancreatic beta cells, leading to increased insulin release and subsequent reduction in blood glucose levels.
Pioglitazone
Pioglitazone activates peroxisome proliferator-activated receptor gamma (PPAR-γ), enhancing insulin sensitivity and glucose metabolism.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
It is unsafe to consume alcohol with Glucomust-PM Tablet ER.
High Risk
Pregnancy
Glucomust-PM Tablet ER is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Medical Advice
Driving
It is not known whether Glucomust-PM Tablet ER alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Exercise Caution
Liver
Glucomust-PM Tablet ER should be used with caution in patients with liver disease. Dose adjustment of Glucomust-PM Tablet ER may be needed. Please consult your doctor. Use of Glucomust-PM Tablet ER is not recommended in patients with severe liver disease.
Regular Checkup
Breastfeeding
Glucomust-PM Tablet ER is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Consult Doctor
Kidney
Glucomust-PM Tablet ER is probably unsafe to use in patients with kidney disease and should be avoided. Please consult your doctor.
Regular Checkup
Customer Reviews
0 reviews for Glucomust-PM Tablet ER